This is a preview of subscription content, log in via an institution to check access.
References
Austin, S. et al. JAMA 268, 516–519 (1992).
Cartmell, T. et al. J. Physiol. 549, 653–664 (2003).
Leday, G.R.G. et al. Biol. Psychiatry http://dx.doi.org/10.1016/j.biopsych.2017.01.021 (2017).
Dowlati, Y. et al. Biol. Psychiatry 67, 446–457 (2010).
Zhu, C.B., Blackely, R.D. & Hewlett, W.A. Neuropsychopharmacology 31, 2121–2131 (2006).
Pasco, J. et al. Br. J. Psychiatry 197, 372–377 (2010).
Khandaker, G.M. et al. JAMA Psychiatry 71,1121–1128 (2014).
Valentine, A.D. et al. Sem. Oncol. 25, 39–47 (1998).
Ridker, P.M. Cir. Res. 118, 145–156 (2016).
Raison, C.L. et al. JAMA Psychiatry 70, 31–41 (2013).
Powel, T.R. et al. Eur. Neuropsychopharmacol. 23, 1105–1114 (2013).
Catteneo, A. et al. Int. J. Neuropsychopharmacol. 19, pyw045 (2016).
Author information
Author notes
Nicole Wetsman is Nature Medicine's news intern in New York.
- Nicole Wetsman
Rights and permissions
About this article
Cite this article
Wetsman, N. Inflammatory illness: Why the next wave of antidepressants may target the immune system. Nat Med 23, 1009–1011 (2017). https://doi.org/10.1038/nm0917-1009
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0917-1009
- Springer Nature America, Inc.